Can the levels of nitric oxide in the urine, serum and tumor tissue be putative markers for bladder cancer?

International Journal of Urology

Volumn 13, Issue 8, 2006, Pages 1079-1085

  Kiliç, Süleyman ^a,c   Bayraktar, Nihayet ^a   Beytur, Ali ^a   Ergin, Hüseyin ^b   Bayraktar, Mehmet ^a   Eǧri, Mücahit ^a  

^a INONU UNIVERSITY   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

^c INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bladder cancer; Chemotherapy; Intravesical BCG; Nitric oxide; Urinary infection

Indexed keywords

BCG VACCINE; NITRIC OXIDE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BLOOD ANALYSIS; BLOOD LEVEL; CANCER PATIENT; CANCER RELAPSE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEMATURIA; HUMAN; MALE; NITRIC OXIDE BLOOD LEVEL; NITRIC OXIDE URINE LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TISSUE DISTRIBUTION; URINALYSIS; URINE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 33746413431     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01481.x     Document Type: Article

References (27)

1. Klotz T, Bloch W, Jacobs G, Niggemann S, Engelmann U, Addicks K. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. Urology 1999; 54: 416-19.
2. Moncada S. The 1991 Ulf von Euler lecture. The 1-arginine nitric oxide pathway. Acta. Physiolol. Scand. 1992; 145: 201-27.
3. Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl Acad. Sci. USA 1994; 91: 9407-11.
4. Cui S, Reichner JS, Mateo RB, Albina JE. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res. 1994; 54: 2462-7.
5. Jenkins DC, Charles IG, Thomsen LL et al. Roles of nitric oxide in tumor growth. Proc. Natl Acad. Sci. USA 1995; 92: 4392-5.
6. Ziehe M, Morbidelli E, Masini E et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 1994; 94: 2036-44.
7. Morcos E, Jansson OT, Adolfsson J, Kratz G, Wiklund NP. Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines. Urology 1999; 53: 1252-7.
8. Jansson OT, Morcos E, Brundin E. Nitric oxide synthase activity in human renal cell carcinoma. J. Urol. 1998; 160: 556-60.
9. Moochhala S, Chhatwal VJ, Chan ST, Ngoi SS, Chia YW, Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996; 17: 1171-4.
10. Xie K, Dong Z, Fidler IJ. Activation of nitric oxide synthase gene for inhibition of cancer metastasis. J. Leukoc. Biol. 1996; 59: 797-803.
11. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994; 54: 1352-4.
12. Klotz T, Bloch W, Volberg C, Engelmann U, Addicks K. Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 1998; 82: 1897-903.
13. Wolf H, Haeckel C, Roessner A. Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Arch. 2000; 437: 662-6.
14. Fleming ID, Cooper JS, Henson DE et al. AJCC Cancer Staging Manual. Lippincott, Philadelphia, 1997.
15. Eijan AM, Piccardo I, Riveros MD et al. Nitric oxide in patients with transitional bladder cancer. J. Surg. Oncol. 2002; 81: 203-8.
16. Khalifa A, Eissa S, Aziz A. Determination of cytosolic citrulline and nitrate as indicators of nitric oxide in bladder cancer: possible association with basic fibroblast growth factor. Clin. Biochem. 1999; 32: 635-8.
17. Bukan N, Sözen S, Coşkun U et al. Serum interleukin-18 and nitric oxide activity in bladder carcinoma. Eur. Cytokine. Netw. 2003; 14: 163-7.
18. Mizutani Y, Terachi T, Okada Y, Yoshida O. Effect of surgical stress on immune function in patients with urologic cancer. Int. J. Urol. 1996; 3: 426-34.
19. Radomski MW, Jenkins DC, Holmes L, Moncada S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 1991; 51: 6073-8.
20. Carlsson S, Weitzberg E, Wiklund P, Lundberg JON. Intravesical nitric oxide delivery for prevention of catheter-associated urinary tract infections. Antimicrob. Agents Chemother. 2005; 49: 2352-5.
21. Smith SD, Wheeler MA, Weiss RM. Nitric oxide synthase: an endogenous source of elevated nitrite in infected urine. Kidney Int. 1994; 45: 586-91.
22. Lundberg JON, Carlsson S, Engstrand L, Morcos E, Wiklund NP, Weitzberg E. Urinary nitrite: more than a marker of infection. Urology 1997; 50: 189-91.
23. Poljakovic M, Persson K. Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am. J. Physiol. Renal Physiol. 2003; 284: F22-31.
24. Mitropoulos DN. Novel insights into the mechanism of action of intravesical immunomodulators. In Vivo 2005; 19: 611-21.
25. Jansson OT, Morcos E, Brundin L et al. The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer. Br. J. Cancer 1998; 78: 588-92.
26. Morcos E, Jansson OT, Adolfsson J, Ehren I, Wiklund NP. Bacillus Calmette-Guérin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells. J. Urol. 2001; 165: 678-82.
27. Mitropoulos D, Petsis D, Kyroudi-Voulgari A, Kouloukoussa M, Zervas A, Dimopoulos C. The effect of intravesical Bacillus Calmette-Guérin instillations on the expression of inducible nitric oxide synthase in humans. Nitric Oxide 2005; 13: 36-41.